Ultragenyx Pharmaceutical Inc
NASDAQ: RARE
$58.49
-$0.87 (-1.5%)
Closing Price on September 17, 2024
RARE Articles
Monday's top analyst upgrades and downgrades included Accenture, Boeing, CRISPR Therapeutics, DraftKings, Illumina, Lyft, McDonald's, Southwest Airlines and Teladoc Health.
Published:
These three biotech stocks have gigantic upside and a fair amount of risk as well. While they are not suited for conservative accounts, the companies all have had very positive data and their shares...
Published:
Wednesday's top analyst upgrades, downgrades and initiations included Altice USA, CenturyLink, Cigna, Emerson Electric, Foot Locker, Groupon, Lululemon Athletica, Nike, State Street and Walt Disney.
Published: